NASHVILLE, Tenn.– Dxcover, a UK-based diagnostics company specializing in early cancer detection, has officially launched its U.S. operations with the opening of a new headquarters in Nashville, Tennessee. The move marks a significant step in the company’s push to commercialize its AI-powered PANAROMIC™ multiomic cancer screening test in the U.S., the world’s largest healthcare market.
The expansion positions Dxcover in one of the country’s leading life sciences hubs and lays the groundwork for clinical collaborations, R&D growth, and local manufacturing of its diagnostic platform. The company’s proprietary Drop. Dry. Detect.™ method uses infrared spectroscopy and artificial intelligence to analyze blood samples for early cancer indicators, offering a cost-effective, non-invasive, and scalable alternative to traditional screening approaches.
“The launch of our U.S. headquarters in Nashville represents a major value-building milestone for Dxcover as we accelerate our mission to make early cancer detection accessible everywhere,” said Dr. Matthew J. Baker, CEO and Co-founder of Dxcover. “Nashville’s thriving healthcare ecosystem offers exciting opportunities for collaboration with research institutions, hospitals, and biotech startups focused on precision medicine.”
Dxcover’s PANAROMIC™ platform distinguishes itself from genetic-marker-based screening tests by using a multiomic approach that captures a comprehensive biological fingerprint from a small blood sample. By combining infrared spectroscopy with AI-driven spectral analysis, the technology is designed to detect cancer at earlier stages across multiple tumor types, including brain, colorectal, lung, and pancreatic cancers.
The company’s long-term goal is to make early cancer screening more accessible, especially in underserved populations, supporting global efforts to close healthcare equity gaps. The Nashville hub will also serve as a center for U.S. clinical studies and product development as Dxcover works to bring its technology closer to regulatory approval and market readiness.
Dxcover joins a growing community of innovators in Tennessee’s life sciences sector and plans to actively engage with regional partners such as Life Science Tennessee and BioTN to advance cancer diagnostics and expand access to life-saving technologies.
